Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01343810 · ClinicalTrials.gov registry record · NA
Stress Reduction Training to Improve Sleep Quality, Stress Physiology & Cardiovascular Disease (CVD) Risk Markers
A NA study of Cardiovascular Diseases and Sleep, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT01343810: Completed NA study of Cardiovascular Diseases and Sleep, sponsored by Duke University.
NCT01343810 is a NA study of Cardiovascular Diseases and Sleep that has completed, run by Duke University. The registered enrollment target is 87 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01343810, a NA study of Cardiovascular Diseases and Sleep, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to better understand the potential value of reducing stress to ameliorate a cluster of biological and behavioral factors implicated in cardiovascular disease (CVD) risk. These factors include psychological distress, poor sleep quality, and exaggerated physiological responses to emotional stress. Results will be used to develop an innovative brief intervention to reduce risk for CVD by improving sleep quality, ameliorating psychological distress, and attenuating stress physiology.
Primary Outcome
Sleep quality will be assessed using 3 different methods: daily sleep diaries, questionnaires and actigraphy.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-Based Stress Reduction (MBSR)
- BEHAVIORAL Mindfulness Based Stress Reduction (MBSR)
Study Locations (1)
North Carolina
- Duke Integrative Medicine - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-10 |
| Phase | NA |
What the finished NCT01343810 record still lists
NCT01343810 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower).
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-Based Stress Reduction (MBSR) is the first listed.
NCT01343810 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01343810 about?
NCT01343810 is a clinical study titled "Stress Reduction Training to Improve Sleep Quality, Stress Physiology & Cardiovascular Disease (CVD) Risk Markers". The goal of this study is to better understand the potential value of reducing stress to ameliorate a cluster of biological and behavioral factors implicated in cardiovascular disease (CVD) risk. These factors include psychological distress, poor sleep quality, and exaggerated physiological response...
What is the current status of trial NCT01343810?
This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2010-09. Estimated completion is 2013-10.
What conditions does trial NCT01343810 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Sleep, Inflammation, Stress, Psychological.
What interventions are being tested in trial NCT01343810?
The interventions under investigation include: Mindfulness-Based Stress Reduction (MBSR) (BEHAVIORAL), Mindfulness Based Stress Reduction (MBSR) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01343810?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01343810 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01343810's enrollment target sits among peer trials
87 205th of 300 higher than 95 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia